Ignite Creation Date:
2024-05-06 @ 6:55 PM
Last Modification Date:
2024-10-26 @ 2:57 PM
Study NCT ID:
NCT05828511
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2023-04-12
Brief Title:
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
Sponsor:
Regeneron Pharmaceuticals
Organization:
Regeneron Pharmaceuticals
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-12-19
Start Date Type:
ACTUAL
Primary Completion Date:
2035-11-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2035-11-02
Completion Date Type:
ESTIMATED
First Submit Date:
2023-04-12
First Submit QC Date:
April 12 2023
Study First Post Date:
2023-04-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-08
Last Update Post Date:
2024-07-03
Last Update Post Date Type:
ACTUAL